Arun Kumar

Arun Kumar

Auto-generated profile, based on publicly available information

Arun Kumar

Department of Pharmacy, School of Health Sciences, Central University of South Bihar, Gaya 824209, India

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
RMRashita Makker
Rashita Makker
Tapan BehlTapan Behl
Tapan Behl
Simona BungăuSimona Bungău
Simona Bungău
Gökhan ZenginGökhan Zengin
Gökhan Zengin
VMVineet Mehta
Vineet Mehta
Roxana OanceaRoxana Oancea
Roxana Oancea
Neurological diseases are one of the major healthcare issues worldwide. Posed lifestyle changes are associated with drastically increased risk of chronic illness and diseases, posing a substantial healthcare and financial burden to society globally. Researchers aim to provide fine treatment for ailing disorders with minimal exposed side effects. In recent decades, several studies on functional foods have been initiated to obtain foods that have fewer side effects and increased therapeutic activity. Hence, an attempt has been made to unravel several extraction techniques to acquire essential bioactive compounds or phytochemicals from therapeutically active food products. This has led to the conception of the term functional foods being meddled with other similar terms like “pharmafoods,” “medifoods”, “vitafoods”, or “medicinal foods”. With a dire need to adhere towards healthy options, the demand of nutraceuticals is widely increasing to combat neurological interventions. An association between food habits and the individual lifestyle with neurodegeneration has been manifested, thereby proposing the role of nutraceuticals as prophylactic treatment for neurological interventions. The current review covers some of the major neurological disorders and nutraceutical therapy in the prevention of disease.

1 April 2020 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
AKArun Kumar
Arun Kumar
TBTapan Behl
Tapan Behl
SCSwati Chadha
Swati Chadha

19 April 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Tapan BehlTapan Behl
Tapan Behl
Gabriele RocchettiGabriele Rocchetti
Gabriele Rocchetti
SCSwati Chadha
Swati Chadha
Gökhan ZenginGökhan Zengin
Gökhan Zengin
Simona BungăuSimona Bungău
Simona Bungău
Domenico MontesanoDomenico Montesano
Domenico Montesano
To date, the leading causes of mortality and morbidity worldwide include viral infections, such as Ebola, influenza virus, acquired immunodeficiency syndrome (AIDS), severe acute respiratory syndrome (SARS) and recently COVID-19 disease, caused by the SARS-CoV-2 virus. Currently, we can count on a narrow range of antiviral drugs, especially older generation ones like ribavirin and interferon which are effective against viruses in vitro but can often be ineffective in patients. In addition to these, we have antiviral agents for the treatment of herpes virus, influenza virus, HIV and hepatitis virus. Recently, drugs used in the past especially against ebolavirus, such as remdesivir and favipiravir, have been considered for the treatment of COVID-19 disease. However, even if these drugs represent important tools against viral diseases, they are certainly not sufficient to defend us from the multitude of viruses present in the environment. This represents a huge problem, especially considering the unprecedented global threat due to the advancement of COVID-19, which represents a potential risk to the health and life of millions of people. The demand, therefore, for new and effective antiviral drugs is very high. This review focuses on three fundamental points: (1) presents the main threats to human health, reviewing the most widespread viral diseases in the world, thus describing the scenario caused by the disease in question each time and evaluating the specific therapeutic remedies currently available. (2) It comprehensively describes main phytochemical classes, in particular from plant foods, with proven antiviral activities, the viruses potentially treated with the described phytochemicals. (3) Consideration of the various applications of drug delivery systems in order to improve the bioavailability of these compounds or extracts. A PRISMA flow diagram was used for the inclusion of the works. Taking into consideration the recent dramatic events caused by COVID-19 pandemic, the cry of alarm that denounces critical need for new antiviral drugs is extremely strong. For these reasons, a continuous systematic exploration of plant foods and their phytochemicals is necessary for the development of new antiviral agents capable of saving lives and improving their well-being.

11 June 2022 in Seminars in Cancer Biology
Verified
Journal Article
Closed access
ADAsmita Deka Dey
Asmita Deka Dey
ABAshkan Bigham
Ashkan Bigham
YEYasaman Esmaeili
Yasaman Esmaeili
MAMilad Ashrafizadeh
Milad Ashrafizadeh
FMFarnaz Dabbagh Moghaddam
Farnaz Dabbagh Moghaddam
Pooyan MakvandiPooyan Makvandi
Pooyan Makvandi

2 December 2020 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
AKArun Kumar
Arun Kumar
TBTapan Behl
Tapan Behl
SJSumit Jamwal
Sumit Jamwal
IKIshnoor Kaur
Ishnoor Kaur
ASArchit Sood
Archit Sood
PKPuneet Kumar
Puneet Kumar

13 January 2021 in Journal of Nanoparticle Research
Verified
Journal Article
Closed access
PDF file
Mahmood BaraniMahmood Barani
Mahmood Barani
M QammarM Qammar
M Qammar
Abbas RahdarAbbas Rahdar
Abbas Rahdar
Rabia ArshadRabia Arshad
Rabia Arshad
AKArun Kumar
Arun Kumar
George Z. KyzasGeorge Z. Kyzas
George Z. Kyzas